Clinical Trials in Baltimore

Showing 1221-1240 of 23,476 trials

A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine

NCT06615375

In this challenge study, the bioconjugate candidate vaccine Shigella4V2 will be tested for its ability to induce an immune response that protects healthy adult volunteers from infection with a wild-type Shigella sonnei strain compared to participants receiving placebo.

Shigellosis

LimmaTech Biologics AG120 participantsStarted Nov 2024

Atlanta, Georgia, United States • Baltimore, Maryland, United States • Cincinnati, Ohio, United States

COMPLETEDPhase 2< 1 mile

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06049017

The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severely active ulcerative colitis.

Colitis, Ulcerative

Janssen Research & Development, LLC252 participantsStarted Oct 2023

Anaheim, California, United States • Newport Beach, California, United States • San Diego, California, United States +174 more locations

A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

Find Trials by Condition in Baltimore

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Rapid HCV Treatment Access for Persons Who Use Drugs

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Developing Brain, Impulsivity and Compulsivity

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

A Study of Lu AF82422 in Participants With Multiple System Atrophy

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer